News

Filter

Current filters:

None

Popular Filters

8176 to 8200 of 8449 results

AstraZeneca gains rights to Heptares GPCR drug for $6.25 million upfront

31-05-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that it has entered a four-year…

AstraZenecaDermatologicalsHeptares TherapeuticsLicensingNeurologicalPharmaceuticalResearch

Chiesi, Eli Lilly and Bayer named for breaches of the ABPI Code of Practice

31-05-2011

The UK subsidiaries of Italy’s Chiesi, US drug major Eli Lilly (NYSE: LLY) and Germany’s Bayer…

BayerChiesi FarmaceuticiEli LillyEuropeLevitraNeurologicalPharmaceuticalRegulationReproductiveYasmin

Sanofi enters accord with DNDi to generate new drugs for neglected tropical diseases

31-05-2011

French drug major Sanofi (Euronext: SAN) and Drugs for Neglected Diseases initiative (DNDi), a not-for-profit…

PharmaceuticalResearchSanofiTropical diseases

Roche joins forces with ChemRar on developing new antithrombotic drug for Russia

30-05-2011

Swiss pharmaceutical major Roche (ROG: SIX) and Russian TeaReks company, a subsidiary of ChemRar, Roche's…

Cardio-vascularChemRar Hi-TechEuropeLicensingPharmaceuticalRocheTeaReks

German pharma hails progress against multiple sclerosis

30-05-2011

Multiple sclerosis (MS) sufferers should soon have access to a range of drugs that offer better protection…

EuropeMarkets & MarketingNeurologicalPharmaceuticalResearch

US GPhA calls on House Appropriations Committee to protect funding for FDA; welcomes Solicitor General’s action

30-05-2011

The USA’s Generic Pharmaceutical Association (GPhA) has written to House Appropriations Committee…

FinancialGenericsLegalNorth AmericaRegulation

Important implications of Abbott win in US patent ruling

30-05-2011

US health care major Abbott Laboratories (NYSE: ABT) last week won a US appeals court ruling that will…

Abbott LaboratoriesLegalNorth AmericaPatentsPharmaceutical

Efficacy and stroke concerns halt trial of Abbott cholesterol drug Niaspan combo

27-05-2011

US health care major Abbott Laboratories (NYSE ABT) has halted its AIM-HIGH clinical trial of Niaspan…

Abbott LaboratoriesCardio-vascularNiaspanPharmaceuticalResearchSimvastatin

Canada’s Quebec Province overhauls cancer drug evaluation

27-05-2011

The Canadian Province of Quebec, which has the highest incidence of new cancer cases in the country,…

North AmericaPharmaceuticalRegulation

German approval for GW and Almirall’s Sativex for spasticity due to MS

27-05-2011

Spain’s leading drugmaker Almirall (ALM) and UK-based originator of the cannabis based product GW…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

HAI Europe injects public health perspective into European Research and Innovation Framework

27-05-2011

Consumer group Health Action International (HAI) Europe has submitted a response to the European Commission…

EuropeHealthcarePharmaceuticalResearch

Two more product approvals in Russia for India’s Claris

27-05-2011

Claris Lifesciences (CLAR: IN), one of the largest sterile injectables pharmaceutical companies in India,…

Antibiotics and Infectious diseasesClaris LifesciencesEuropeFluconazoleGenericsLevofloxacinRegulation

Major stakeholders optimistic about future of drug development, but differ on defining value

27-05-2011

Biopharmaceutical executives, managed care executives, physicians and patients with chronic illness foresee…

HealthcareNorth AmericaPharmaceuticalResearch

Synovate Healthcare launches Hyperlipidemia Monitor in Asia-Pacific

27-05-2011

Synovate Healthcare, the health care specialist unit of market research firm Synovate, says it has launched…

Asia-PacificCardio-vascularHealthcarePharmaceutical

US Senators accuse Sanofi over lobbying FDA on generic Lovenox

26-05-2011

US Senate Finance Committee Chairman Max Baucus (Democrat, Montana) and senior Committee Member Chuck…

Cardio-vascularGenericsLovenoxNorth AmericaPharmaceuticalRegulationSanofi

Patient access and industry competitiveness at stake in EU Transparency Directive review, says EFPIA

26-05-2011

With the review of the European Union’s Transparency Directive (Directive 89/105/EEC) gaining momentum,…

EuropeLegalPharmaceuticalPricingResearch

Emerging markets continue to drive Nycomed in first quarter 2011

26-05-2011

Independent Swiss drugmaker Nycomed, which is the subject of an agreed 9.6 billion-euro takeover by Japan’s…

FinancialNycomedPharmaceutical

Vaccine side effects under the microscope in Australia

26-05-2011

Australia’s Gillard government yesterday released an independent assessment of the nation's management…

Asia-PacificPharmaceuticalRegulationVaccines

UK’s NICE recommends naftidrofuryl oxalate for symptoms of peripheral arterial disease

26-05-2011

The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending…

Cardio-vascularEuropeMerck SerononaftidrofurylPharmaceuticalPraxilenePricingRegulation

8176 to 8200 of 8449 results

Back to top